ID23053A - Karboksamida yang digunakan sebagai agonis 5-ht <if> - Google Patents
Karboksamida yang digunakan sebagai agonis 5-ht <if>Info
- Publication number
- ID23053A ID23053A IDW991411A ID991411A ID23053A ID 23053 A ID23053 A ID 23053A ID W991411 A IDW991411 A ID W991411A ID 991411 A ID991411 A ID 991411A ID 23053 A ID23053 A ID 23053A
- Authority
- ID
- Indonesia
- Prior art keywords
- agonist
- carboxamide used
- carboxamides
- amino
- carboxamide
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 150000003857 carboxamides Chemical class 0.000 title 1
- GZJDNSCLZKOHHP-UHFFFAOYSA-N 7-amino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide Chemical class N1C2=CC=C(C(N)=O)C=C2C2=C1CC(N)CC2 GZJDNSCLZKOHHP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyamides (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
- Semiconductor Integrated Circuits (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Insulating Materials (AREA)
- Conductive Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4858497P | 1997-06-04 | 1997-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID23053A true ID23053A (id) | 2000-01-20 |
Family
ID=21955349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW991411A ID23053A (id) | 1997-06-04 | 1998-01-06 | Karboksamida yang digunakan sebagai agonis 5-ht <if> |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0882726B1 (id) |
| JP (1) | JP2002502419A (id) |
| KR (1) | KR20010013409A (id) |
| CN (1) | CN1259049A (id) |
| AT (1) | ATE240953T1 (id) |
| AU (1) | AU729786B2 (id) |
| BR (1) | BR9810610A (id) |
| CA (1) | CA2291624A1 (id) |
| DE (1) | DE69814735T2 (id) |
| DK (1) | DK0882726T3 (id) |
| EA (1) | EA001718B1 (id) |
| ES (1) | ES2199410T3 (id) |
| HU (1) | HUP0004142A3 (id) |
| ID (1) | ID23053A (id) |
| IL (1) | IL133279A0 (id) |
| NO (1) | NO995963D0 (id) |
| NZ (1) | NZ501569A (id) |
| PL (1) | PL337221A1 (id) |
| PT (1) | PT882726E (id) |
| TR (1) | TR199903014T2 (id) |
| WO (1) | WO1998055115A1 (id) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1937300A (en) | 1998-12-11 | 2000-06-26 | Eli Lilly And Company | Indole derivatives and their use as 5-HT1F agonists |
| EP1184373A4 (en) | 1999-04-20 | 2004-10-20 | Meiji Seika Kaisha | TRICYCLIC CONNECTIONS |
| EP1200086A4 (en) * | 1999-08-04 | 2009-05-27 | Icagen Inc | THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY |
| US6495550B2 (en) | 1999-08-04 | 2002-12-17 | Icagen, Inc. | Pyridine-substituted benzanilides as potassium ion channel openers |
| ATE380176T1 (de) | 1999-08-04 | 2007-12-15 | Icagen Inc | Benzanilide als öffner des kaliumkanals |
| TWI263497B (en) | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
| MXPA05011223A (es) | 2003-04-18 | 2006-01-26 | Lilly Co Eli | Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas 5-htif. |
| UA82711C2 (en) | 2003-09-12 | 2008-05-12 | Эли Лилли Энд Компани | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| DE602004008338T2 (de) | 2003-12-17 | 2008-05-29 | Eli Lilly And Co., Indianapolis | Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten |
| CA2617473A1 (en) | 2005-08-08 | 2007-02-15 | Astellas Pharma Inc. | Acylguanidine derivative or salt thereof |
| CA2677995A1 (en) * | 2007-02-07 | 2008-08-14 | Astellas Pharma Inc. | Acylguanidine derivative |
| CN102753171A (zh) | 2009-04-02 | 2012-10-24 | 科鲁西德制药公司 | 2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲酰胺的组合物 |
| AR080703A1 (es) * | 2010-03-22 | 2012-05-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-carbazol, moduladores de receptores de prostaglandina d2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos alergicos o inmunitarios tales como asma. |
| US8697876B2 (en) | 2010-04-02 | 2014-04-15 | Colucid Pharmaceuticals, Inc. | Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists |
| GB2516138C (en) * | 2013-04-09 | 2015-12-09 | Cresset Biomolecular Discovery Ltd | The treatment of inflammatory disorders |
| TWI826514B (zh) | 2018-09-04 | 2023-12-21 | 美商美國禮來大藥廠 | 用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥 |
| TWI829107B (zh) | 2019-07-09 | 2024-01-11 | 美商美國禮來大藥廠 | 大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體,以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備 |
| CN112125836A (zh) * | 2020-10-15 | 2020-12-25 | 濮阳惠成电子材料股份有限公司 | 有机电致光电材料中间体n-苯基咔唑-3-羧酸乙酯的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226566D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
| WO1996029075A1 (en) * | 1995-03-20 | 1996-09-26 | Eli Lilly And Company | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| DE69610793T2 (de) * | 1995-06-23 | 2001-05-03 | Eli Lilly And Co., Indianapolis | 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole |
-
1998
- 1998-01-06 ID IDW991411A patent/ID23053A/id unknown
- 1998-06-01 KR KR19997011410A patent/KR20010013409A/ko not_active Withdrawn
- 1998-06-01 HU HU0004142A patent/HUP0004142A3/hu unknown
- 1998-06-01 CN CN98805776A patent/CN1259049A/zh active Pending
- 1998-06-01 NZ NZ501569A patent/NZ501569A/en unknown
- 1998-06-01 EA EA199901113A patent/EA001718B1/ru not_active IP Right Cessation
- 1998-06-01 WO PCT/US1998/003340 patent/WO1998055115A1/en not_active Ceased
- 1998-06-01 AU AU77955/98A patent/AU729786B2/en not_active Ceased
- 1998-06-01 JP JP50237299A patent/JP2002502419A/ja not_active Ceased
- 1998-06-01 CA CA002291624A patent/CA2291624A1/en not_active Abandoned
- 1998-06-01 PL PL98337221A patent/PL337221A1/xx unknown
- 1998-06-01 TR TR1999/03014T patent/TR199903014T2/xx unknown
- 1998-06-01 IL IL13327998A patent/IL133279A0/xx unknown
- 1998-06-01 BR BR9810610-4A patent/BR9810610A/pt not_active IP Right Cessation
- 1998-06-02 ES ES98304343T patent/ES2199410T3/es not_active Expired - Lifetime
- 1998-06-02 AT AT98304343T patent/ATE240953T1/de not_active IP Right Cessation
- 1998-06-02 EP EP98304343A patent/EP0882726B1/en not_active Expired - Lifetime
- 1998-06-02 PT PT98304343T patent/PT882726E/pt unknown
- 1998-06-02 DK DK98304343T patent/DK0882726T3/da active
- 1998-06-02 DE DE69814735T patent/DE69814735T2/de not_active Expired - Fee Related
-
1999
- 1999-12-03 NO NO995963A patent/NO995963D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE240953T1 (de) | 2003-06-15 |
| PL337221A1 (en) | 2000-08-14 |
| HUP0004142A3 (en) | 2002-10-28 |
| JP2002502419A (ja) | 2002-01-22 |
| AU7795598A (en) | 1998-12-21 |
| KR20010013409A (ko) | 2001-02-26 |
| NZ501569A (en) | 2001-11-30 |
| CN1259049A (zh) | 2000-07-05 |
| BR9810610A (pt) | 2000-09-12 |
| TR199903014T2 (xx) | 2000-05-22 |
| WO1998055115A1 (en) | 1998-12-10 |
| EP0882726B1 (en) | 2003-05-21 |
| DE69814735D1 (de) | 2003-06-26 |
| IL133279A0 (en) | 2001-04-30 |
| EA199901113A1 (ru) | 2000-08-28 |
| ES2199410T3 (es) | 2004-02-16 |
| NO995963L (no) | 1999-12-03 |
| EP0882726A1 (en) | 1998-12-09 |
| NO995963D0 (no) | 1999-12-03 |
| CA2291624A1 (en) | 1998-12-10 |
| HUP0004142A2 (hu) | 2001-05-28 |
| DK0882726T3 (da) | 2003-09-22 |
| PT882726E (pt) | 2003-09-30 |
| DE69814735T2 (de) | 2004-03-25 |
| AU729786B2 (en) | 2001-02-08 |
| EA001718B1 (ru) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID23053A (id) | Karboksamida yang digunakan sebagai agonis 5-ht <if> | |
| DE69319976D1 (de) | 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline | |
| CA2354023A1 (en) | Phenylglycine derivatives | |
| PT618190E (pt) | 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas | |
| ES2188095T3 (es) | Carboxamidas heterociclicas. | |
| DE69713402D1 (de) | Liganden des neuropeptids y | |
| ID18883A (id) | Pesaing 5-ht 1f | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| ES2189968T3 (es) | Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS. | |
| DK0842661T3 (da) | Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning | |
| DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
| DK0810220T3 (da) | Arylacrylamidderivater som 5-HT1-agonister eller -antagonister | |
| DK0952154T3 (da) | N-acyl- og N-aroylaralkylamider | |
| BG105710A (en) | 5ht1 antagonists for antidepressant therapy | |
| BG105539A (bg) | Елетриптан хидробромид монохидрат | |
| PT1204659E (pt) | Benzofuranos serotoninergicos | |
| ID25478A (id) | Agonis 5-ht1f | |
| TR200001122T2 (tr) | Farmasötikler olarak bifenil türevleri. | |
| EP0412941A3 (en) | Phospholipids for the treatment of multiple sclerosis |